Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice
2008

Improving Gene Delivery to the Heart in Mice

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Christina A. Pacak, Yoshihisa Sakai, Bijoy D. Thattaliyath, Cathryn S. Mah, Barry J. Byrne

Primary Institution: Powell Gene Therapy Center, College of Medicine, University of Florida

Hypothesis

Which promoter confers the highest level of cardiac specific expression and broad biodistribution of expression across cardiac and skeletal muscle?

Conclusion

The α-MHC promoter is most effective for cardiac-specific expression, while the Des promoter provides expression in both cardiac and skeletal muscle.

Supporting Evidence

  • The α-MHC promoter was found to be the most cardiac specific.
  • The Des promoter provided expression in both heart and skeletal muscle.
  • The study involved a total of 30 neonatal mice, with 6 mice per promoter group.

Takeaway

Scientists tested different gene delivery methods in baby mice to see which one works best for targeting the heart and muscles. They found that some methods are better at delivering genes just to the heart.

Methodology

Five different promoters were compared using AAV9 vectors administered via IV to neonatal mice, followed by measurement of LacZ expression.

Limitations

The study was limited to neonatal mice and may not directly translate to other age groups or species.

Participant Demographics

BALB/c neonatal mice

Digital Object Identifier (DOI)

10.1186/1479-0556-6-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication